Reductions in sugar sales from soft drinks in the UK from 2015 to 2018 von Bandy, L K, Scarborough, P, Harrington, R A, Rayner, M, Jebb, S A

Volltext

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation von Lopes, R D, Pieper, K S, Horton, J R, Al-Khatib, S M, Newby, L K, Mehta, R H, Van de Werf, F, Armstrong, P W, Mahaffey, K W, Harrington, R A, Ohman, E M, White, H D, Wallentin, L, Granger, C B

Volltext

Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meetin... von Berger, J., Eikelboom, J. W., Quinlan, D. J., Guyatt, G., Büller, H. R., Sobieraj‐Teague, M., Harrington, R. A., Hirsh, J.

Volltext

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease von KONG, D. F, CALIFF, R. M, MILLER, D. P, MOLITERNO, D. J, WHITE, H. D, HARRINGTON, R. A, TCHENG, J. E, LINCOFF, A. M, HASSELBLAD, V, TOPOL, E. J

Volltext

Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? von Fox, K A A, Eikelboom, J W, Anand, S S, Bhatt, D L, Bosch, J, Connolly, S J, Harrington, R A, Steg, P G, Yusuf, S

Volltext

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes von Roe, M.T., Mahaffey, K.W., Kilaru, R., Alexander, J.H., Akkerhuis, K.M., Simoons, M.L., Harrington, R.A., Tardiff, B.E., Granger, C.B., Ohman, E.M., Moliterno, D.J., Lincoff, A.M., Armstrong, P.W., Van de Werf, F., Califf, R.M., Topol, E.J.

Volltext

Risk Stratification and Therapeutic Decision Making in Acute Coronary Syndromes von Ohman, E. Magnus, Granger, Christopher B, Harrington, Robert A, Lee, Kerry L

Volltext

Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes von Bhatt, Deepak L., Peterson, Eric D., Harrington, Robert A., Ou, Fang-Shu, Cannon, Christopher P., Gibson, C. Michael, Kleiman, Neal S., Brindis, Ralph G., Peacock, W. Frank, Brener, Sorin J., Menon, Venu, Smith, Sidney C., Pollack, Charles V., Gibler, W. Brian, Ohman, E. Magnus, Roe, Matthew T.

Volltext

Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial von Husted, S., Harrington, R. A., Cannon, C. P., Storey, R. F., Mitchell, P., Emanuelsson, H.

Volltext

Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis von Chi, G., Goldhaber, S. Z., Kittelson, J. M., Turpie, A. G. G., Hernandez, A. F., Hull, R. D., Gold, A., Curnutte, J. T., Cohen, A. T., Harrington, R. A., Gibson, C. M.

Volltext

Acute profound thrombocytopenia after c7E3 Fab (abciximab) therapy von BERKOWITZ, S. D, HARRINGTON, R. A, RUND, M. M, TCHENG, J. E

Volltext

Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention von Popma, Jeffrey J., Ohman, E. Magnus, Weitz, Jeffrey, Lincoff, A. Michael, Harrington, Robert A., Berger, Peter

Volltext

A randomized, repeat‐dose, pharmacodynamic and safety study of an antidote‐controlled factor IXa inhibitor von CHAN, M. Y., RUSCONI, C. P., ALEXANDER, J. H., TONKENS, R. M., HARRINGTON, R. A., BECKER, R. C.

Volltext

First experience with direct, selective factor Xa inhibition in patients with non‐ST‐elevation acute coronary syndromes: results of the XaNADU‐ACS Trial von ALEXANDER, J. H., YANG, H., BECKER, R. C., KODAMA, K., GOODMAN, S., DYKE, C. K., KLEIMAN, N. S., HOCHMAN, J. S., BERGER, P. B., COHEN, E. A., LINCOFF, A. M., BURTON, J. R., BOVILL, E. G., KAWAI, C., ARMSTRONG, P. W., HARRINGTON, R. A.

Volltext

Predictors of 90-day outcome in patients stabilized after acute coronary syndromes von Newby, L.K, Bhapkar, M.V, White, H.D, Topol, E.J, Dougherty, F.C, Harrington, R.A, Smith, M.C, Asarch, L.F, Califf, R.M

Volltext

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT von Akkerhuis, K.M, Deckers, J.W, Boersma, E, Harrington, R.A, Stepinska, J, Mahaffey, K.W, Wilcox, R.G, Lincoff, A.M, Keltai, M, Topol, E.J, Califf, R.M, Simoons, M.L

Volltext

Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy von Sane, David C, Damaraju, Lakshmi V, Topol, Eric J, Cabot, Catherine F, Mascelli, Mary Ann, Harrington, Robert A, Simoons, Maarten L, Califf, Robert M

Volltext

Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes von Harrington, Robert A.

Volltext

Percutaneous revascularization of chronic coronary occlusions: An overview von Puma, Joseph A., Sketch, Michael H., Tcheng, James E., Harrington, Robert A., Phillips, Harry R., Stack, Richard S., Califf, Robert M.

Volltext

Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes von MARK, D. B, HARRINGTON, R. A, LINCOFF, A. M, CALIFF, R. M, NELSON, C. L, TSIATIS, A. A, BUELL, H, MAHAFFEY, K. W, DAVIDSON-RAY, L, TOPOL, E. J

Volltext